EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
OneAscent Family Office LLC Makes New $613,000 Investment in Astrazeneca Plc $AZN - Stock Observer
Astrazeneca Plc $AZN Shares Purchased by Cibc World Market Inc. - Daily Political
AstraZeneca CEO says AI is reshaping drug development - and helping boost the odds of success
Is It Too Late To Consider AstraZeneca (LSE:AZN) After Its 30.8% One-Year Surge?
AstraZeneca (AZN) Stock: Bernstein Identifies 37% Upside Potential in Overlooked Segment
Diamond Blackfan Anemia Market Unlocking New Revenue Opportunities and Strategic Expansion by 2036 - DelveInsight | Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, Merck KGaA
AstraZeneca PLC (AZN) Shares Surge 3.1% -- What GF Score of 83 T
AstraZeneca (AZN) Engages with FDA Leadership on Rare Disease Initiatives
Low-dose Zoladex won't be available in Australia from November. What might that mean for you?
Other news to note for June 4, 2026 | BioWorld
GKV Capital Management Co. Inc. Takes $1.58 Million Position in Astrazeneca Plc $AZN - Daily Political
A first-in-human, open-label multicentre Phase 1 study of the orally administered E7386 in patients with selected advanced neoplasms
Influence of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on the management of blood pressure in Japanese patients with diabetes
AZN: Recent Drug Approvals And Key Readouts Will Support Bullish Repricing
AstraZeneca CEO: AI is affecting every part of our company
3 UK shares to consider holding in a Stocks and Shares ISA for a decade
SCS Capital Management LLC Reduces Position in Astrazeneca Plc $AZN - Stock Observer
Martin Investment Management LLC Has $54.32 Million Stock Position in Astrazeneca Plc $AZN - Stock Observer
Leading Bank maintains sell on AstraZeneca at 11,500p as ASCO glow fails to resolve key pipeline questions
Norges Bank Makes New Investment in Astrazeneca Plc $AZN - Stock Observer
Northwestern Mutual Wealth Management Co. Has $15.13 Million Stock Position in Astrazeneca Plc $AZN - Stock Observer
AstraZeneca (AZN) Benefits from New FDA Guidance on Gene Therapy Development
AstraZeneca (AZN) Reports Promising Phase III Trial Results for Camizestrant
AstraZeneca's (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point
ANCA Vasculitis Market to Witness Transformational Growth Opportunities by 2036 - DelveInsight | CSL, Amgen, NS Pharma, Amgen, GlaxoSmithKline, AstraZeneca, Chemocentry, Staidson (Beijing) Biopharma
Regulatory actions for June 2, 2026 | BioWorld
)
ELRIG unveils keynote speakers for Drug Discovery 2026
Neoadjuvant pembrolizumab plus chemotherapy in germline BRCA-mutated early triple-negative breast cancer: a multicenter real-world cohort
A homoeriodictyol sodium mouthwash reduces bitterness sensitivity in patients with gynecological cancer receiving carboplatin-based chemotherapy
Asthma Pipeline Shows Strong Momentum as 80+ Pharma Companies in the Race | DelveInsight
AstraZeneca Scores In Liver Cancer On Its Path To $40 Billion In Oncology Sales
AIM ImmunoTech (AIM) Advances Enrollment in Pancreatic Cancer Trial
AstraZeneca (AZN) Reports Positive Results in Phase III Trial for HCC Treatment
Multiple Clinical Trial Data for Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist, to be Presented at ADA 2026 | Morningstar
AstraZeneca's IMFINZI-Based Regimen Cuts Progression Risk By 30% In Liver Cancer Trial
Assessing McCormick (MKC) Valuation After Cindy Hoots Joins The Board Of Directors
Astrazeneca's (AZN) "Buy" Rating Reiterated at Barclays - Daily Political
Regulatory actions for June 1, 2026 | BioWorld
SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
Regulatory factor X 7 limits Myc activity during B cell activation and suppresses Myc-dependent lymphomagenesis
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
Citi Keeps Their Buy Rating on AstraZeneca (AZN)
Legal & General Group Plc Trims Stock Holdings in Astrazeneca Plc $AZN - Daily Political
)
Cambridge duo Arm and AstraZeneca rewrite corporate history
AstraZeneca (AZN) Gains Approval for Imfinzi in Bladder Cancer Treatment
25,037 Shares in Astrazeneca Plc $AZN Purchased by SBI Okasan Asset Management Co.Ltd. - Stock Observer
Thoroughbred Financial Services LLC Makes New $1.49 Million Investment in AstraZeneca PLC $AZNCF - Stock Observer
CelLBxHealth signs master services agreement with AstraZeneca
AZN Gains FDA Approval for New Bladder Cancer Treatment
Texas Capital Bank Wealth Management Services Inc Acquires Shares of 3,416 Astrazeneca Plc $AZN - Daily Political
What McCormick (MKC)'s Move to Add a Digital and AI Strategist to Its Board Means for Shareholders - Simply Wall St News
AstraZeneca's durvalumab approved in U.S. for NMIBC patients
AstraZeneca, Roche to boost digital pathology uptake in APAC and more briefs
IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
Simple Blood Count May Help Predict Flare-Up Risk in Asthma | MDedge
Sun Pharmaceuticals Industries Ltd Futures Share Price & Chart Today | IIFL Capital
Preoperative onapristone-XR in postmenopausal women with progesterone receptor-positive (PgR+)/HER2-negative early breast cancer: SOLTI-1802 ONAWA trial results
AstraZeneca (AZN) Receives FDA Approval for Imfinzi in Bladder Cancer Treatment
AstraZeneca (AZN) Gains FDA Approval for Imfinzi in Bladder Cancer Treatment
AstraZeneca (AZN) Secures U.S. Approval for Imfinzi Combination Therapy
AstraZeneca: Oncology and Rare Disease Data at ASCO 2026
Cary Street Partners Financial LLC Makes New Investment in AstraZeneca PLC $AZNCF - Zolmax
Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy
AZN's Patent Granted in Canada Strengthens Position in Male Infertility Treatment
FDA delays ruling on AstraZeneca drug after negative adcomm vote
William Blair Investment Management LLC Raises Stake in Astrazeneca Plc $AZN - Stock Observer
AstraZeneca falls 7% as Q4 net profit declines 23%; here's a trading strategy for the pharma stock
3,842 Shares in Astrazeneca Plc $AZN Acquired by M3 Wealth Management LLC - Stock Observer
UK Value Opportunities: Serica Energy Among 3 Stocks Priced Below Intrinsic Estimates
Preparing for a time when living to age 120 is commonplace | AfricaPulse.com
Bleakley Financial Group LLC Has $15.34 Million Holdings in Astrazeneca Plc $AZN - Stock Observer
Hantz Financial Services Inc. Buys 39,244 Shares of Astrazeneca Plc $AZN - Stock Observer
Main Street Research LLC Makes New Investment in Astrazeneca Plc $AZN - Stock Observer
GPS Wealth Strategies Group LLC Decreases Stock Holdings in Astrazeneca Plc $AZN - Zolmax
AstraZeneca's Camizestrant: EU Approves Game-Changing Breast Cancer Pill Amid US Concerns, ETPharma
Insider Sell: Mani Sharma Sells Shares of AstraZeneca PLC
FDA Approves AstraZeneca And Daiichi's Datroway For Treating Metastatic Breast Cancer
AstraZeneca (AZN) Gains U.S. Approval for Datroway in Breast Cancer Treatment
AstraZeneca Breast Cancer Drug Recommended for Approval by EU Regulator | Morningstar
AstraZeneca, Daiichi Sankyo's Datroway Gets Approval In US For Treatment Of Breast Cancer
AZN Receives Positive EU Approval Recommendation for Enhertu
Datroway® Approved in the U.S. as First TROP2 Directed Antibody Drug Conjugate for First-Line Treatment of Patients with Metastatic Triple Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates | Morningstar
AstraZeneca (AZN) Showcases Promising Clinical Data at ASCO Annual Meeting
AstraZeneca's Camizestrant Receives Positive Opinion from EMA
EU regulator recommends positive opinion of AstraZeneca's experimental breast cancer drug
Vestmark Advisory Solutions Inc. Acquires 93,186 Shares of Astrazeneca Plc $AZN - Stock Observer
Keudell Morrison Wealth Management Buys New Position in Astrazeneca Plc $AZN - Stock Observer
Astrazeneca (NYSE:AZN) Receives "Sell" Rating from Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft Reaffirms Sell Rating for Astrazeneca (NYSE:AZN) - Zolmax
Global Retirement Partners LLC Has $9.85 Million Stock Position in Astrazeneca Plc $AZN - Daily Political
25,822 Shares in AstraZeneca PLC $AZNCF Acquired by Burling Wealth Partners LLC - Stock Observer
How VEPPANU Approval Frames Expectations For AstraZeneca's Camizestrant In ESR1 Disease
Compugen Ltd. (NASDAQ:CGEN) Q1 2026 Earnings Call Transcript
Astrazeneca Plc (NYSE:AZN) Receives $205.33 Average Target Price from Analysts - Zolmax
Harvest Portfolios Group Inc. Sells 39,131 Shares of Astrazeneca Plc $AZN
Astrazeneca Plc $AZN Shares Acquired by Envestnet Portfolio Solutions Inc.
Gabelli Funds LLC Cuts Stock Holdings in Astrazeneca Plc $AZN - Stock Observer
Ultra-high tumor mutation burden breast cancer: genomic profiling and real-world immunotherapy results
AstraZeneca, Roche join forces to boost AI-based cancer pathology across Asia
Treatment strategies in giant cell arteritis and polymyalgia rheumatica: beyond glucocorticoids
AstraZeneca News
US Monetary Policy Pivot: Non-Farm Payrolls, Inflation Fears, and Potential Rate Hikes
Netanyahu-Trump Rift Exposed: Ceasefire Talks Put Israeli Election Stakes in Jeopardy
US May Jobs Report: A Critical Indicator for the Fed's Interest Rate Path
Latest news
Show moreMarket Pulse: Dollar Rises, Gold Dips Post-US Jobs Data; Geopolitical Tensions Simmer
US May Jobs Report Signals Slowing Growth: A Deep Dive into Market Indicators
Hormuz Strait Oil Tanker Activity Shifts: Increased Secrecy and Market Fragmentation
US May Jobs Report Exceeds Expectations, Bolstering Economic Resilience and Shifting Fed Rate Outlook
